Syndax has a strong cash position and a significant market opportunity with Revuforj and Niktimvo. Check out my ...
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...
News-Medical.Net on MSN4d
New drug target identified for treating acute myeloid leukemiaA team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...
The following is a summary of “Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk ...
Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...
The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...
Scientists have identified a promising new drug target for acute myeloid leukemia, a deadly blood cancer with a five-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback